(1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SH3BP2 mRNA CTD PMID:36331819 1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of SH3BP2 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO Sh3bp2 (Rattus norvegicus) 6480464 [APC protein affects the susceptibility to 1 and 2-Dimethylhydrazine] which results in decreased expression of SH3BP2 mRNA CTD PMID:27840820 1,2-dimethylhydrazine increases expression EXP 6480464 1 and 2-Dimethylhydrazine results in increased expression of SH3BP2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of SH3BP2 mRNA CTD PMID:17555576 17beta-estradiol increases expression ISO SH3BP2 (Homo sapiens) 6480464 Estradiol results in increased expression of SH3BP2 mRNA CTD PMID:23019147 17beta-estradiol decreases expression ISO Sh3bp2 (Rattus norvegicus) 6480464 Estradiol results in decreased expression of SH3BP2 mRNA CTD PMID:32145629 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SH3BP2 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Sh3bp2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SH3BP2 mRNA CTD PMID:33387578 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Sh3bp2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SH3BP2 mRNA CTD PMID:32277265 2,4-dinitrotoluene affects expression ISO Sh3bp2 (Rattus norvegicus) 6480464 2 and 4-dinitrotoluene affects the expression of SH3BP2 mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO SH3BP2 (Homo sapiens) 6480464 Lactic Acid results in increased expression of SH3BP2 mRNA CTD PMID:30851411 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of SH3BP2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases methylation EXP 6480464 bisphenol S results in increased methylation of SH3BP2 exon CTD PMID:33297965 4,4'-sulfonyldiphenol affects methylation EXP 6480464 bisphenol S affects the methylation of SH3BP2 gene CTD PMID:31683443 6-propyl-2-thiouracil increases expression ISO Sh3bp2 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of SH3BP2 mRNA CTD PMID:24780913 acrolein multiple interactions ISO SH3BP2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of SH3BP2 mRNA CTD PMID:32845096 acrylamide decreases expression ISO SH3BP2 (Homo sapiens) 6480464 Acrylamide results in decreased expression of SH3BP2 mRNA CTD PMID:32763439 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SH3BP2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO SH3BP2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of SH3BP2 promoter CTD PMID:30157460 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of SH3BP2 mRNA CTD PMID:17178593 all-trans-retinoic acid decreases expression ISO SH3BP2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of SH3BP2 mRNA CTD PMID:23724009 all-trans-retinoic acid increases expression ISO SH3BP2 (Homo sapiens) 6480464 Tretinoin results in increased expression of SH3BP2 mRNA CTD PMID:33167477 antirheumatic drug decreases expression ISO SH3BP2 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of SH3BP2 mRNA CTD PMID:24449571 azoxystrobin multiple interactions ISO Sh3bp2 (Rattus norvegicus) 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SH3BP2 mRNA CTD PMID:33854195 benzene-1,2,4-triol increases expression ISO SH3BP2 (Homo sapiens) 6480464 hydroxyhydroquinone results in increased expression of SH3BP2 mRNA CTD PMID:17572062 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of SH3BP2 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO SH3BP2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SH3BP2 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO SH3BP2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SH3BP2 5' UTR and Benzo(a)pyrene affects the methylation of SH3BP2 promoter CTD PMID:27901495 Benzo[k]fluoranthene increases expression EXP 6480464 benzo(k)fluoranthene results in increased expression of SH3BP2 mRNA CTD PMID:26377693 bisphenol A decreases expression ISO SH3BP2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of SH3BP2 mRNA CTD PMID:22576693 bisphenol A decreases methylation ISO SH3BP2 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of SH3BP2 gene CTD PMID:31601247 bisphenol A increases expression ISO Sh3bp2 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of SH3BP2 mRNA CTD PMID:30816183 more ... bisphenol A affects expression ISO Sh3bp2 (Rattus norvegicus) 6480464 bisphenol A affects the expression of SH3BP2 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO SH3BP2 (Homo sapiens) 6480464 bisphenol A results in increased methylation of SH3BP2 gene CTD PMID:22576693 butanal decreases expression ISO SH3BP2 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of SH3BP2 mRNA CTD PMID:26079696 C60 fullerene increases expression ISO Sh3bp2 (Rattus norvegicus) 6480464 fullerene C60 results in increased expression of SH3BP2 mRNA CTD PMID:19167457 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 cefaloridine increases expression ISO Sh3bp2 (Rattus norvegicus) 6480464 Cephaloridine results in increased expression of SH3BP2 mRNA CTD PMID:18500788 chlorpyrifos multiple interactions ISO Sh3bp2 (Rattus norvegicus) 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SH3BP2 mRNA CTD PMID:33854195 cisplatin multiple interactions ISO SH3BP2 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SH3BP2 mRNA CTD PMID:27392435 cisplatin increases expression ISO SH3BP2 (Homo sapiens) 6480464 Cisplatin results in increased expression of SH3BP2 mRNA CTD PMID:27392435 copper(II) sulfate increases expression ISO SH3BP2 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of SH3BP2 mRNA CTD PMID:19549813 Cuprizon increases expression ISO Sh3bp2 (Rattus norvegicus) 6480464 Cuprizone results in increased expression of SH3BP2 mRNA CTD PMID:27523638 cyclosporin A increases expression ISO SH3BP2 (Homo sapiens) 6480464 Cyclosporine results in increased expression of SH3BP2 mRNA CTD PMID:25562108 D-glucose increases expression EXP 6480464 Glucose results in increased expression of SH3BP2 mRNA CTD PMID:17178593 dicrotophos increases expression ISO SH3BP2 (Homo sapiens) 6480464 dicrotophos results in increased expression of SH3BP2 mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO SH3BP2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SH3BP2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO SH3BP2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of SH3BP2 mRNA CTD PMID:29803840 endosulfan increases expression ISO Sh3bp2 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of SH3BP2 mRNA CTD PMID:29391264 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of SH3BP2 mRNA CTD PMID:35436446 fenthion decreases expression EXP 6480464 Fenthion results in decreased expression of SH3BP2 mRNA CTD PMID:34813904 flutamide increases expression ISO Sh3bp2 (Rattus norvegicus) 6480464 Flutamide results in increased expression of SH3BP2 mRNA CTD PMID:24136188 and PMID:24793618 FR900359 affects phosphorylation ISO SH3BP2 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of SH3BP2 protein CTD PMID:37730182 gentamycin increases expression ISO Sh3bp2 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of SH3BP2 mRNA CTD PMID:33387578 glucose increases expression EXP 6480464 Glucose results in increased expression of SH3BP2 mRNA CTD PMID:17178593 glyphosate increases expression EXP 6480464 Glyphosate results in increased expression of SH3BP2 mRNA CTD PMID:35897073 glyphosate multiple interactions ISO Sh3bp2 (Rattus norvegicus) 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SH3BP2 mRNA CTD PMID:33854195 hydroquinone increases expression ISO SH3BP2 (Homo sapiens) 6480464 hydroquinone results in increased expression of SH3BP2 mRNA CTD PMID:31256213 imidacloprid multiple interactions ISO Sh3bp2 (Rattus norvegicus) 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SH3BP2 mRNA CTD PMID:33854195 inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SH3BP2 mRNA CTD PMID:36331819 lead(0) decreases expression ISO SH3BP2 (Homo sapiens) 6480464 Lead results in decreased expression of SH3BP2 mRNA CTD PMID:19921347 leflunomide increases expression ISO SH3BP2 (Homo sapiens) 6480464 leflunomide results in increased expression of SH3BP2 mRNA CTD PMID:28988120 mercury atom increases expression ISO SH3BP2 (Homo sapiens) 6480464 Mercury results in increased expression of SH3BP2 mRNA CTD PMID:19937285 mercury(0) increases expression ISO SH3BP2 (Homo sapiens) 6480464 Mercury results in increased expression of SH3BP2 mRNA CTD PMID:19937285 methoxychlor affects methylation ISO Sh3bp2 (Rattus norvegicus) 6480464 Methoxychlor affects the methylation of SH3BP2 gene CTD PMID:35440735 ozone multiple interactions ISO SH3BP2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of SH3BP2 mRNA and [Air Pollutants results in increased abundance of Ozone] which affects the expression of SH3BP2 mRNA CTD PMID:32845096 and PMID:35430440 paclitaxel decreases expression ISO SH3BP2 (Homo sapiens) 6480464 Paclitaxel results in decreased expression of SH3BP2 protein CTD PMID:15907983 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of SH3BP2 mRNA CTD PMID:17562736 paracetamol decreases expression ISO Sh3bp2 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of SH3BP2 mRNA CTD PMID:33387578 paracetamol increases expression ISO SH3BP2 (Homo sapiens) 6480464 Acetaminophen results in increased expression of SH3BP2 mRNA CTD PMID:29067470 perfluorononanoic acid increases expression ISO SH3BP2 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in increased expression of SH3BP2 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SH3BP2 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SH3BP2 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO SH3BP2 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of SH3BP2 mRNA CTD PMID:36326898 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of SH3BP2 mRNA CTD PMID:19270015 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of SH3BP2 mRNA CTD PMID:23091169 pirinixic acid multiple interactions EXP 6480464 NCF1 protein inhibits the reaction [pirinixic acid results in decreased expression of SH3BP2 mRNA] CTD PMID:17950772 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of SH3BP2 mRNA CTD PMID:17950772 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of SH3BP2 mRNA CTD PMID:28903501 prothioconazole increases expression ISO SH3BP2 (Homo sapiens) 6480464 prothioconazole results in increased expression of SH3BP2 mRNA CTD PMID:35048155 quercetin increases expression ISO SH3BP2 (Homo sapiens) 6480464 Quercetin results in increased expression of SH3BP2 mRNA CTD PMID:15309432 rac-lactic acid increases expression ISO SH3BP2 (Homo sapiens) 6480464 Lactic Acid results in increased expression of SH3BP2 mRNA CTD PMID:30851411 SB 431542 multiple interactions ISO SH3BP2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SH3BP2 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO Sh3bp2 (Rattus norvegicus) 6480464 Silicon Dioxide results in increased expression of SH3BP2 mRNA CTD PMID:32721576 silicon dioxide decreases expression ISO SH3BP2 (Homo sapiens) 6480464 Silicon Dioxide results in decreased expression of SH3BP2 mRNA CTD PMID:25351596 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of SH3BP2 mRNA CTD PMID:25123088 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SH3BP2 mRNA CTD PMID:31919559 thiabendazole multiple interactions ISO Sh3bp2 (Rattus norvegicus) 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SH3BP2 mRNA CTD PMID:33854195 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of SH3BP2 mRNA CTD PMID:29264374 trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of SH3BP2 mRNA CTD PMID:35537566 urethane decreases expression ISO SH3BP2 (Homo sapiens) 6480464 Urethane results in decreased expression of SH3BP2 mRNA CTD PMID:28818685 valproic acid affects expression ISO SH3BP2 (Homo sapiens) 6480464 Valproic Acid affects the expression of SH3BP2 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO SH3BP2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SH3BP2 mRNA CTD PMID:27188386 valproic acid decreases expression ISO SH3BP2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of SH3BP2 mRNA CTD PMID:23179753 more ... vinclozolin decreases expression ISO Sh3bp2 (Rattus norvegicus) 6480464 vinclozolin results in decreased expression of SH3BP2 mRNA CTD PMID:23034163